Alligator Bioscience Sells Mitazalimab Rights for $0.75M Upfront

The agreement includes up to $108M in milestones tied to approvals and sales, plus mid-single-digit royalties, with total payments capped at $250M. Closing is expected within 30 days, subject to conditions.